468 related articles for article (PubMed ID: 28944858)
21. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
Zhang X; Zhang L; Chen M; Liu D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
[TBL] [Abstract][Full Text] [Related]
22. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
Zhan M; Zhao X; Wang H; Chen W; Xu S; Wang W; Shen H; Huang S; Wang J
Tumour Biol; 2016 Aug; 37(8):10553-62. PubMed ID: 26852750
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
24. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2.
Li XL; Li SZ; Wu CX; Xing XH
Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
[TBL] [Abstract][Full Text] [Related]
25. Clinical implication of TMPRSS4 expression in human gallbladder cancer.
Wu XY; Zhang L; Zhang KM; Zhang MH; Ruan TY; Liu CY; Xu JY
Tumour Biol; 2014 Jun; 35(6):5481-6. PubMed ID: 24532432
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer.
Wang WX; Lin QF; Shen D; Liu SP; Mao WD; Ma G; Qi WD
Tumour Biol; 2014 Jan; 35(1):419-23. PubMed ID: 23918306
[TBL] [Abstract][Full Text] [Related]
27. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
[TBL] [Abstract][Full Text] [Related]
28. CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas.
Jia N; Dong S; Zhao G; Gao H; Li X; Zhang H
J Cancer Res Ther; 2016; 12(2):892-6. PubMed ID: 27461670
[TBL] [Abstract][Full Text] [Related]
29. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis.
Sun KK; Hu PP; Xu F
J Cell Biochem; 2018 Apr; 119(4):3099-3110. PubMed ID: 29058818
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.
Ye YY; Mei JW; Xiang SS; Li HF; Ma Q; Song XL; Wang Z; Zhang YC; Liu YC; Jin YP; Hu YP; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu YB
Cell Death Dis; 2018 Mar; 9(3):410. PubMed ID: 29540696
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
[TBL] [Abstract][Full Text] [Related]
34. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.
Jiang ZB; Ma BQ; Feng Z; Liu SG; Gao P; Yan HT
Cell Cycle; 2021 Feb; 20(3):308-319. PubMed ID: 33459111
[TBL] [Abstract][Full Text] [Related]
35. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
36. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
38. High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.
Kono H; Nakamura M; Ohtsuka T; Nagayoshi Y; Mori Y; Takahata S; Aishima S; Tanaka M
Oncol Rep; 2013 Jul; 30(1):17-24. PubMed ID: 23660842
[TBL] [Abstract][Full Text] [Related]
39. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
[TBL] [Abstract][Full Text] [Related]
40. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
